Keith A. Goldan - 13 Jun 2022 Form 3 Insider Report for Syndax Pharmaceuticals Inc (SNDX)

Signature
/s/ Michael A. Metzger, Attorney-in-Fact
Issuer symbol
SNDX
Transactions as of
13 Jun 2022
Net transactions value
$0
Form type
3
Filing time
15 Jun 2022, 16:05:01 UTC
Previous filing
17 Mar 2022
Next filing
03 Feb 2023

No securities are beneficially owned.